Confirma

Kate Madden Yee

Nov 8, 2006

Kirkland, WA-based computer-aided detection (CAD) developer Confirma plans to focus on two products at this year's RSNA show: CADalog, a study recall program that allows radiologists to view a patient's previous studies next to current ones; and CADstream, its breast MR image processing CAD technology.

CADstream automates analysis, reporting, and interventional planning of studies and incorporates the American College of Radiology's BI-RADS Atlas. It also features morphology categorization through its volume analysis tool, multiplanar reformatting (MPR), angiogenesis maps, maximum intensity projections (MIPs), and a CAD analysis tool, SureLoc, for MR-guided interventional procedures. SureLoc is now compatible with all interventional guidance methods and equipment, according to the company.

In May, Confirma boosted CADstream's visibility with two partnerships, one with Berlex Imaging of Wayne, NJ, and another with Medipattern of Toronto. Berlex will offer CADstream via a customer accrual program; Medipattern will package its B-CAD MRI advanced morphology analysis tool with CADstream.

By Kate Madden Yee
AuntMinnie.com contributing writer
November 9, 2006

Copyright © 2006 AuntMinnie.com

MRI radiomics model predicts risk in women with DCIS

April 1, 2025

Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.

Do radiologists trust mammography AI software?

March 18, 2025

Breast Mammo 400

Mammographic breast density not affected by multivitamins

March 17, 2025

Fes Pet2 Thumbnail

FES-PET shows promise staging patients with low-grade breast cancer

March 4, 2025

MRI radiomics model predicts risk in women with DCIS

An MRI-based radiomics model shows potential for distinguishing low- from high-risk cases of ductal carcinoma in situ (DCIS), an early form of breast cancer.

April 1, 2025

Do radiologists trust mammography AI software?

By Erik L. Ridley

A large-scale prospective trial exploring the use of mammography AI software in a breast cancer screening program has found that recalls were lower when cases were flagged by AI.

March 18, 2025

Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.

Mammographic breast density not affected by multivitamins

By AuntMinnie.com staff writers

The use of multivitamin supplements has no influence on mammographic breast density, researchers have reported.

March 17, 2025

Breast Mammo 400

FES-PET shows promise staging patients with low-grade breast cancer

F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.

March 4, 2025

Fes Pet2 Thumbnail

Interventional breast radiology can boost sustainability efforts

By Amerigo Allegretto

Minimally invasive breast interventions can contribute to best sustainability practices, suggest presentations given at ECR 2025.

March 3, 2025

Breast ultrasound effective for screening women with dense tissue

By Kate Madden Yee

Ultrasound can play a significant role in cancer detection for women with dense breast tissue where access to supplemental screening with MRI and/or contrast mammography is limited, researchers have reported.

February 25, 2025

Breast Ultrasound

1 in 20 women around the world diagnosed with breast cancer

By Amerigo Allegretto

About one in 20 women globally are diagnosed with breast cancer and women living in low- to middle-income countries are at higher risk.

February 24, 2025

Women with BRCA1/2 germline mutations are often denied breast MRI

By Kate Madden Yee

Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.

January 3, 2025

Mri Breast Cancer

Study shows women will pay for AI breast cancer screening exam

Some clinical practices have elected to offer enhanced workflows enabled by AI, at an additional cost.

December 5, 2024

Abnormal mammogram (left) compared with normal mammogram. Image courtesy of the RSNA.

Sectra inks 5-year deal with MaineGeneral Health

By AuntMinnie.com staff writers

Sectra has secured a five-year agreement with MaineGeneral Health to use Sectra One Cloud and its modules for radiology and breast imaging.

October 15, 2024

Sectra Rsna 2019 400

New theranostics pairing tested in breast cancer patients

By Kate Madden Yee

A new theranostics pairing of molecular imaging and radioligand therapy shows promise as a treatment option for patients with metastatic breast cancer, researchers have found.

July 31, 2024

Black women less likely to undergo preoperative breast MRI

By Kate Madden Yee

Black women diagnosed with breast cancer are less likely than their white counterparts to undergo preoperative MRI, researchers report.

July 10, 2024

Mri Breast Cancer

Page 1 of 570